Head-to-head · WeighScore
No BS RX vs Prime Doctor RX
By GLP-1 ScorecardUpdated
Score comparison
No BS RX has the higher recorded score — 82.8/100 to 73/100.
No BS RX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. No BS RX publishes separate prices for standard compounded, low-dose and brand-name programs.
Before you choose
Before comparing the headline prices, the No BS RX review and the Prime Doctor RX review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.
If neither one fits, No BS RX vs QuickMD and Prime Doctor RX vs Strut Health compare each of them with another graded program, and the list of alternatives to No BS RX ranks the programs closest to No BS RX on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the Direct Meds review covers one graded close to these two, at 77.6/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | No BS RX | Prime Doctor RX |
|---|---|---|
| WeighScore | 82.8/100 | 73/100 |
| Grade | B− | C |
| Site position | #23 | #80 |
| Semaglutide | $149/mo advertised for standard compounded injection; low-dose priced separately | $249 every 4 weeks (thirteen charges a year, not twelve) |
| Tirzepatide | $225/mo advertised for standard compounded injection; low-dose priced separately | $339 every 4 weeks (thirteen charges a year, not twelve) |
| Coverage | Confirm program availability for your state | Not publicly listed |
| Brand-name access | Yes | Not confirmed |
| Oral / sublingual | Yes | Yes |
Strengths
- Displays monthly and prepaid amounts by program
- Advertises consultation, medication, shipping and messaging in the compounded plans
- Lists branded Ozempic and Zepbound separately
What to consider
- The $115 headline applies to low-dose programs
- Plans renew automatically at the then-current rate
- Cancellation generally stops future billing without refunding the current period
Strengths
- The full ladder for all three weight-loss products and for TRT sits on the homepage before any intake
- The asterisk is honored: every card's footnote says the starting price is the 52-week prepay, in full
- The four-week shipping cycle is disclosed in that same footnote rather than left to a bank statement
- Names OpenLoop Health as the group providing telehealth evaluation and prescribing
- Hormone-care initial labs are priced at $50 rather than left unstated
What to consider
- Its own arithmetic proves the 28-day cycle — $3,497 divided by thirteen is exactly $269, and nothing on the page divides cleanly by calendar months
- A year of month-to-month tirzepatide therefore costs $4,407, not the $4,068 that per-month pricing implies
- The $269 and $179 headlines are 52-week prepays; month to month they are $339 and $249
- The Terms of Service name no company, no LLC and no address, and state availability is confirmed only during the intake
- The $50 lab fee sits in a "how it works" step rather than in the pricing table
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.